Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011

Table 2 Different specimens, isolation times, and genotypes of clinical samples

No. patient	Isolation time	Specimen	CAI* genotype
CY61A	2010-08-20	blood	25-35
CY61B	2010-08-20	ascitic fluid	25-35
CY65A	2010-02-25	blood	11-20
CY65B	2010-02-25	catheter fluid	11-20
CY66A	2010-03-30	blood	21-21
CY66B	2010-03-29	catheter fluid	21-21
CY69A	2010-08-20	blood	16-21
CY69B	2010-08-23	catheter fluid	16-21
CY141A	2011-01-02	blood	32-46
CY141B	2011-01-07	catheter fluid	32-46
CY119A	2010-01-10	blood	16-18
CY119B	2010-01-07	ascitic fluid	16-18
CY123A	2010-04-14	ascitic fluid	17-28
CY123B	2010-04-14	catheter fluid	17-28
CY68A	2010-03-23	blood	25-33
CY68B	2010-03-20	catheter fluid	25-33
CY68C	2010-03-22	ascitic fluid	25-33
CY154A	2011-09-26	blood	16-21
CY154B	2011-09-26	catheter fluid	16-21
CY154C	2011-10-01	bile	16-21
CY154D	2011-10-04	ascitic fluid	16-21

*CAI CA is the abbreviation of Candida albicans, followed by the roman numeral I.

ISSN: 1471-2334